期刊文献+

Vasculogenic Mimicry and Aberrant Expression of HIF-lα/E-cad Are Associated with Worse Prognosis of Esophageal Squamous Cell Carcinoma 被引量:9

Vasculogenic Mimicry and Aberrant Expression of HIF-lα/E-cad Are Associated with Worse Prognosis of Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 Summary: This study aims to find good markers for predicting the prognosis of patients with eso- phageal squamous cell carcinoma (ESCC). Vasculogenic mimicry (VM) and the expression of hy- poxia inducible factor-1α(HIF-1α)/E-cad protein in ESCC were investigated by immunostaining. The association between VM, HIF-1α/E-cad and clinicopathologic characteristics and 5-year-survival rate of patients with ESCC was analyzed. A total of 160 ESCC specimens were involved in this study and 28 specimens of normal esophageal mucosa served as controls. VM channels were identified in 78 (48.75%) of the 160 ESCC specimens and none of the normal esophageal mucosa was found to have VM. The rates of high-expression of HIF-1αand E-cad in ESCC were 43.75% and 38.75%, while the rates in control were 17.86% and 71.43%, respectively (P〈0.05 for all). VM and the expression levels of HIF-1α and E-cad were significantly related to lymph node metastasis, serosa infiltration, PTNM staging and 5-year-survival rates of patients with ESCC (P〈0.05 for all). VM was positively corre- lated with HIF-1α but negatively with E-cad, and HIF-let was negatively correlated with E-cad (P〈0.001 for all). The 5-year-survival rate of patients with ESCC was 6.41% (5/78) in VM group and 65% (52/82) in non-VM group, 7.14% (5/70) in high HIF-1α expression group and 57.78% (52/90) in low HIF-1α expression group. Oppositely, the 5-year-survival rate in high E-cad expression group was 80.65% (50/62) and that in low E-cad expression group was 7.37% (7/98) (P〈0.05 for all). Cox multifactor regression analysis indicated that lymph node metastasis, PTNM stage, VM and expres- sion levels of HIF-1α and E-cad were independent risk factors of patients with ESCC (P〈0.05 for all). Combined detection ofVM, HIF-1α and E-cad plays an important role in predicting the invasion, me- tastasis and prognosis of patients with ESCC. Summary: This study aims to find good markers for predicting the prognosis of patients with eso- phageal squamous cell carcinoma (ESCC). Vasculogenic mimicry (VM) and the expression of hy- poxia inducible factor-1α(HIF-1α)/E-cad protein in ESCC were investigated by immunostaining. The association between VM, HIF-1α/E-cad and clinicopathologic characteristics and 5-year-survival rate of patients with ESCC was analyzed. A total of 160 ESCC specimens were involved in this study and 28 specimens of normal esophageal mucosa served as controls. VM channels were identified in 78 (48.75%) of the 160 ESCC specimens and none of the normal esophageal mucosa was found to have VM. The rates of high-expression of HIF-1αand E-cad in ESCC were 43.75% and 38.75%, while the rates in control were 17.86% and 71.43%, respectively (P〈0.05 for all). VM and the expression levels of HIF-1α and E-cad were significantly related to lymph node metastasis, serosa infiltration, PTNM staging and 5-year-survival rates of patients with ESCC (P〈0.05 for all). VM was positively corre- lated with HIF-1α but negatively with E-cad, and HIF-let was negatively correlated with E-cad (P〈0.001 for all). The 5-year-survival rate of patients with ESCC was 6.41% (5/78) in VM group and 65% (52/82) in non-VM group, 7.14% (5/70) in high HIF-1α expression group and 57.78% (52/90) in low HIF-1α expression group. Oppositely, the 5-year-survival rate in high E-cad expression group was 80.65% (50/62) and that in low E-cad expression group was 7.37% (7/98) (P〈0.05 for all). Cox multifactor regression analysis indicated that lymph node metastasis, PTNM stage, VM and expres- sion levels of HIF-1α and E-cad were independent risk factors of patients with ESCC (P〈0.05 for all). Combined detection ofVM, HIF-1α and E-cad plays an important role in predicting the invasion, me- tastasis and prognosis of patients with ESCC.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2013年第3期385-391,共7页 华中科技大学学报(医学英德文版)
基金 supported by grants from the National Natural Science Foundation of China (No. 81171465) Natural Science Research Program of Education Bureau of Anhui Province (No. KJ2013B141)
关键词 esophageal squamous cell carcinoma vasculogenic mimicry hypoxia inducible factor-let E-CADHERIN PROGNOSIS esophageal squamous cell carcinoma vasculogenic mimicry hypoxia inducible factor-let E-cadherin prognosis
  • 相关文献

参考文献5

二级参考文献67

  • 1Maija H Zile.Abnormal β-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China[J].World Journal of Gastroenterology,2001,7(4):542-546. 被引量:22
  • 2Parkin DM.Global cancer statistics in the year 2000.Lancet Oncol 2001; 2:533-543.
  • 3Dachs GU,Patterson AV,Firth JD,Ratcliffe PJ,Townsend KM,Stratford IJ,et al.Targeting gene expression to hypoxic tumor cells.Nat Med 1997; 3:515-520.
  • 4Jiang BH,Semenza GL,Bauer C,Marti HH.Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.Am J Physiol 1996; 271:C1172-C1180.
  • 5Pugh CW,Ratcliffe PJ.Regulation of angiogenesis by hypoxia:role of the HIF system.Nat Med 2003; 9:677-684.
  • 6Schofield C J,Ratcliffe PJ.Oxygen sensing by HIF hydroxylases.Nat Rev Mol Cell Biol 2004; 5:343-354.
  • 7Maxwell PH,Ratcliffe PJ.Oxygen sensors and angiogenesis.Semin Cell Dev Biol 2002; 13:29-37.
  • 8Semenza GL.Targeting HIF-1 for cancer therapy.Nat Rev Cancer 2003; 3:721-732.
  • 9Covello KL,Kehler J,Yu HW,Gordan JD,Arsham AM,Hu CJ,et al.HIF-2 alpha regulates Oct-4:effects of hypoxia on stem cell function,embryonic development,and tumor growth.Genes Dev 2006; 20:557-570.
  • 10Sato M,Tanaka T,Maemura K,Uchiyama T,Sato H,Maeno T,et al.The Pai-1 gene as a direct target of endothelial PAS domain protein-1 in adenocarcinoma A549 cells.Am J Respir Cell Mol Biol 2004; 31:209-215.

共引文献99

同被引文献28

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部